<DOC>
	<DOCNO>NCT01219608</DOCNO>
	<brief_summary>This double-blinded placebo-controlled block randomize study intensive care patient compare enteral glutamine supplementation placebo . The hypothesis improvement clinical paraclinical outcome . The primary endpoint Infection Probability Score ( IPS ) Systemic Inflammatory Response Syndrome ( SIRS ) . Anthropometric measure serum inflammatory mediator compare .</brief_summary>
	<brief_title>Iranian Intensive Care Unit ( ICU ) Glutamine Study</brief_title>
	<detailed_description />
	<criteria>Age 1860 No corticosteroid use No history heart , liver kidney diseases Nutrition nasogastric orogastric Patients tolerate enteral nutrition 48 hour Patients NPO nutritional support start Lactating pregnant woman Kidney failure study A history glutamin supplement use study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>October 2010</verification_date>
</DOC>